Feed CBRS
CB
Cerebras Systems CBRS · NASDAQ
$108.94 -7.66% (-$9.04)
Summary
40 / 100 · Bulios Score
Valuation 0Growth 100Profitability 27Quality 23Debt 82Stability 9
What speaks for it
- Out of every 100 USD of revenue, 47 USD is left as net profit.
- Revenue grew by 175% a year over the last 3 years.
- It holds more cash than debt: $7.43B against $1.49B.
- Analysts expect revenue to grow by 74% this fiscal year.
What to watch
- It reports a profit, yet spends more cash than it brings in.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveP/E today 103.8
Semiconductors industry median
Today you pay 103.8 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
202220232024202520262027
Diluted EPS (USD)
202220232024202520262027
- Analyst estimate
Revenue grew by 175% a year over the last 3 years. For the next fiscal year analysts expect revenue to grow by 74%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $512.4M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $8.61B
Debt $1.49B
It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 0
- Sell 0
Today's price within the analysts' price targets
Today's price $108.94 Average target $300.5
$108.94 $330
The average target of $300.5 is 176% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.